HIT Consultant November 27, 2024
What You Should Know:
– Neoplas Med GmbH, a Greifswald-based medical technology company, has secured an $18M investment from Niterra Ventures Company to further develop and expand its innovative cold plasma wound care technology.
– The latest investment brings Niterra’s total investment in Neoplas Med to $25M, following previous funding rounds in 2022 and 2023.
Transforming Wound Care with Cold Plasma
Neoplas Med is a pioneer in the field of cold plasma technology for medical applications. The company is the only manufacturer of cold plasma products in Europe with European Medical Device Regulation (MDR) certification. Its patented argon jet cold plasma therapy is widely used in leading clinics across Europe and the Middle East. Neoplas Med has developed...
Today's Sponsors
Today's Sponsor